Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results

Our study aims to discern the immediate and intermediate-term oncological outcomes of the patients with small renal mass and who were surgically unfit or were having a bilateral tumor and underwent radiofrequency ablation (RFA) of the mass. We retrospectively and prospectively analyzed the status o...

Full description

Bibliographic Details
Main Authors: Rohit Kumar Singh, Manav Gideon, Rohan Rajendran, Georgie Mathew, Kannan Nair
Format: Article
Language:English
Published: Codon Publications 2023-10-01
Series:Journal of Kidney Cancer and VHL
Subjects:
Online Access:https://jkcvhl.com/index.php/jkcvhl/article/view/303
_version_ 1797648967151910912
author Rohit Kumar Singh
Manav Gideon
Rohan Rajendran
Georgie Mathew
Kannan Nair
author_facet Rohit Kumar Singh
Manav Gideon
Rohan Rajendran
Georgie Mathew
Kannan Nair
author_sort Rohit Kumar Singh
collection DOAJ
description Our study aims to discern the immediate and intermediate-term oncological outcomes of the patients with small renal mass and who were surgically unfit or were having a bilateral tumor and underwent radiofrequency ablation (RFA) of the mass. We retrospectively and prospectively analyzed the status of the patients who were diagnosed to have small renal masses and were biopsy-proven renal cell carcinoma (RCC) cases, who underwent RFA at our institute from the year 2013 to 2022. Patients were followed-up for 3 years. Data regarding complications were analyzed for all patients who underwent renal RFA along with the 3-year recurrence-free survival (RFS) rate. A total of 28 patients were eligible for the study based on our inclusion and exclusion criteria. Their renal function was recorded. They underwent RFA and were followed-up for a period of 3 years for RFS. Four patients out of the total had immediate complications, out of which two developed a hematoma. Three-year-follow-ups showed six recurrences, overall having 78.6% RFS. Post-procedural renal function was stable as documented by Estimated glomerular filtration rate. Oncological results of RFA in patients with small renal masses who are surgically unfit are associated with a low risk of immediate and intermediate-term deterioration of renal function.
first_indexed 2024-03-11T15:38:31Z
format Article
id doaj.art-c9bdb39a94ad4d54b4fa767fa6d1a117
institution Directory Open Access Journal
issn 2203-5826
language English
last_indexed 2024-03-11T15:38:31Z
publishDate 2023-10-01
publisher Codon Publications
record_format Article
series Journal of Kidney Cancer and VHL
spelling doaj.art-c9bdb39a94ad4d54b4fa767fa6d1a1172023-10-26T13:12:20ZengCodon PublicationsJournal of Kidney Cancer and VHL2203-58262023-10-0110410.15586/jkcvhl.v10i4.303Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term ResultsRohit Kumar Singh0Manav Gideon1Rohan Rajendran2Georgie Mathew3Kannan Nair4Department of Urology, Amrita Institute of Medical Sciences, Kochi, India.Mch Urology, Amrita Institute of Medical Sciences, Kochi, India.Department of Urology, Amrita Institute of Medical Sciences, Kochi, India.Department of Urology, Amrita Institute of Medical Sciences, Kochi, India.Department of Urology, Amrita Institute of Medical Sciences, Kochi, India. Our study aims to discern the immediate and intermediate-term oncological outcomes of the patients with small renal mass and who were surgically unfit or were having a bilateral tumor and underwent radiofrequency ablation (RFA) of the mass. We retrospectively and prospectively analyzed the status of the patients who were diagnosed to have small renal masses and were biopsy-proven renal cell carcinoma (RCC) cases, who underwent RFA at our institute from the year 2013 to 2022. Patients were followed-up for 3 years. Data regarding complications were analyzed for all patients who underwent renal RFA along with the 3-year recurrence-free survival (RFS) rate. A total of 28 patients were eligible for the study based on our inclusion and exclusion criteria. Their renal function was recorded. They underwent RFA and were followed-up for a period of 3 years for RFS. Four patients out of the total had immediate complications, out of which two developed a hematoma. Three-year-follow-ups showed six recurrences, overall having 78.6% RFS. Post-procedural renal function was stable as documented by Estimated glomerular filtration rate. Oncological results of RFA in patients with small renal masses who are surgically unfit are associated with a low risk of immediate and intermediate-term deterioration of renal function. https://jkcvhl.com/index.php/jkcvhl/article/view/303ablationcancerkidneyradiofrequencysmall renal mass
spellingShingle Rohit Kumar Singh
Manav Gideon
Rohan Rajendran
Georgie Mathew
Kannan Nair
Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results
Journal of Kidney Cancer and VHL
ablation
cancer
kidney
radiofrequency
small renal mass
title Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results
title_full Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results
title_fullStr Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results
title_full_unstemmed Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results
title_short Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results
title_sort advancing treatment frontiers radiofrequency ablation for small renal mass intermediate term results
topic ablation
cancer
kidney
radiofrequency
small renal mass
url https://jkcvhl.com/index.php/jkcvhl/article/view/303
work_keys_str_mv AT rohitkumarsingh advancingtreatmentfrontiersradiofrequencyablationforsmallrenalmassintermediatetermresults
AT manavgideon advancingtreatmentfrontiersradiofrequencyablationforsmallrenalmassintermediatetermresults
AT rohanrajendran advancingtreatmentfrontiersradiofrequencyablationforsmallrenalmassintermediatetermresults
AT georgiemathew advancingtreatmentfrontiersradiofrequencyablationforsmallrenalmassintermediatetermresults
AT kannannair advancingtreatmentfrontiersradiofrequencyablationforsmallrenalmassintermediatetermresults